User contributions
Jump to navigation
Jump to search
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 00:58, 10 September 2026 (diff | hist) (+68) m Effective dose equivalent (current)
- 00:33, 10 September 2026 (diff | hist) (+35) m Committed effective dose (current)
- 00:28, 10 September 2026 (diff | hist) (+14) m Committed equivalent dose (current)
- 00:26, 10 September 2026 (diff | hist) (+21) m Committed equivalent dose
- 00:20, 10 September 2026 (diff | hist) (0) m Committed equivalent dose
- 15:45, 2 September 2026 (diff | hist) (+14) Committed equivalent dose
- 17:57, 1 September 2026 (diff | hist) (0) Effective dose equivalent
- 17:57, 1 September 2026 (diff | hist) (0) Committed equivalent dose
- 17:56, 1 September 2026 (diff | hist) (0) Committed equivalent dose
- 17:53, 1 September 2026 (diff | hist) (0) Committed effective dose
- 16:01, 15 July 2024 (diff | hist) (0) Derived consideration reference level (current)
- 16:00, 15 July 2024 (diff | hist) (0) m Derived consideration reference level (→from ICRP Publication 136, 2017)
- 14:57, 7 September 2021 (diff | hist) (-34) Utilitarian ethics (current)
- 14:56, 7 September 2021 (diff | hist) (+13) Uptake (current)
- 14:56, 7 September 2021 (diff | hist) (+8) Upper reference levels (current)
- 14:56, 7 September 2021 (diff | hist) (-37) Unsealed source (current)
- 14:55, 7 September 2021 (diff | hist) (+15) Unattached fraction (current)
- 14:34, 7 September 2021 (diff | hist) (+15) Voxel phantom (current)
- 14:34, 7 September 2021 (diff | hist) (-34) Virtue ethics (current)
- 14:34, 7 September 2021 (diff | hist) (-38) Valvular heart disease (current)
- 14:33, 7 September 2021 (diff | hist) (-34) Value judgement (current)
- 14:33, 7 September 2021 (diff | hist) (-25) Xerostomia (current)
- 14:33, 7 September 2021 (diff | hist) (-39) X ray (current)
- 14:32, 7 September 2021 (diff | hist) (-39) Growth hormone (somatotropin) (current)
- 14:31, 7 September 2021 (diff | hist) (-25) Growth fraction (current)
- 14:31, 7 September 2021 (diff | hist) (+8) Growth factor (current)
- 14:30, 7 September 2021 (diff | hist) (-25) Granulocyte-macrophage colony-stimulating factor (current)
- 14:30, 7 September 2021 (diff | hist) (-25) Granulocyte colony-stimulating factor (current)
- 14:29, 7 September 2021 (diff | hist) (+8) Graft vs host disease (current)
- 14:29, 7 September 2021 (diff | hist) (-41) Graded approach (current)
- 14:29, 7 September 2021 (diff | hist) (-24) Rigidity threshold (current)
- 14:28, 7 September 2021 (diff | hist) (-20) Genomic integrity (current)
- 14:28, 7 September 2021 (diff | hist) (+8) GATA binding protein 2 (current)
- 14:28, 7 September 2021 (diff | hist) (+8) Gastroschisis (current)
- 14:27, 7 September 2021 (diff | hist) (+8) Gastrulation (current)
- 14:27, 7 September 2021 (diff | hist) (-39) Gastrointestinal syndrome (current)
- 14:27, 7 September 2021 (diff | hist) (-25) Gamma ray (current)
- 14:27, 7 September 2021 (diff | hist) (-25) Galactic cosmic radiation (current)
- 14:26, 7 September 2021 (diff | hist) (-24) Fractionation sensitivity (current)
- 14:26, 7 September 2021 (diff | hist) (+8) Fractionation and dose delivery patterns (current)
- 14:25, 7 September 2021 (diff | hist) (-37) Fractionation (current)
- 14:25, 7 September 2021 (diff | hist) (0) Fractional absorption in the gastrointestinal tract (current)
- 14:25, 7 September 2021 (diff | hist) (-25) Forbiddenness (current)
- 14:24, 7 September 2021 (diff | hist) (0) Fluoroscopically or computed tomography guided interventions (current)
- 14:24, 7 September 2021 (diff | hist) (+15) Fluence (current)
- 14:24, 7 September 2021 (diff | hist) (-37) Fluoroscopically guided interventions (current)
- 14:24, 7 September 2021 (diff | hist) (-39) Flexible tissues (current)
- 14:23, 7 September 2021 (diff | hist) (-38) Field-size effect (Volume effect) (current)
- 14:23, 7 September 2021 (diff | hist) (-34) Fairness (current)
- 14:22, 7 September 2021 (diff | hist) (+13) Kp index (current)
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
